cytosine has been researched along with Leukemia P388 in 7 studies
Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The best therapeutic response was observed when pyrimidinone was given every 4 days for a total of 7 injections; however, other schedules and dosing frequencies also gave significant responses." | 1.27 | Chemoimmunotherapy of B 16 melanoma and P388 leukemia with cyclophosphamide and pyrimidinones. ( Johnson, MA; Li, LH; Moeller, RB; Wallace, TL, 1984) |
| " However, it produced statistically significant synergistic activity against P388 leukemia when used in combination with cyclophosphamide (CY)." | 1.27 | Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs. ( DeKoning, TF; Li, LH; Wallace, TL, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, LH | 4 |
| Johnson, MA | 1 |
| Moeller, RB | 1 |
| Wallace, TL | 4 |
| Grove, KL | 1 |
| Guo, X | 1 |
| Liu, SH | 1 |
| Gao, Z | 1 |
| Chu, CK | 1 |
| Cheng, YC | 1 |
| Hanaoka, K | 1 |
| Suzuki, M | 1 |
| Kobayashi, T | 1 |
| Tanzawa, F | 1 |
| Tanaka, K | 1 |
| Shibayama, T | 1 |
| Miura, S | 1 |
| Ikeda, T | 1 |
| Iwabuchi, H | 1 |
| Nakagawa, A | 1 |
| Mitsuhashi, Y | 1 |
| Hisaoka, M | 1 |
| Kaneko, M | 1 |
| Tomida, A | 1 |
| Wataya, Y | 1 |
| Nomura, T | 1 |
| Sasaki, T | 1 |
| Matsuda, A | 1 |
| Tsuruo, T | 1 |
| Kurakata, S | 1 |
| Kawaguchi, T | 1 |
| Ichikawa, T | 1 |
| Hasegawa, T | 1 |
| Saneyoshi, M | 1 |
| Wakayama, T | 1 |
| Kato, H | 1 |
| Yukita, A | 1 |
| Nagata, T | 1 |
| DeKoning, TF | 2 |
| Nicholas, JA | 1 |
| Kramer, GD | 1 |
| Wilson, D | 1 |
| Collins, MJ | 1 |
| Richard, KA | 1 |
| Tracey, DE | 1 |
7 other studies available for cytosine and Leukemia P388
| Article | Year |
|---|---|
Chemoimmunotherapy of B 16 melanoma and P388 leukemia with cyclophosphamide and pyrimidinones.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined | 1984 |
Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Colonic Neoplasms; Cytarab | 1995 |
Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biotransformatio | 1999 |
Enzymatic reactivity and anti-tumor activity of 1-(beta-D-arabinofuranosyl)-2-thiocytosine derivatives.
Topics: Animals; Antineoplastic Agents; Arabinonucleosides; Cytosine; Intestines; Leukemia P388; Mice; Model | 2000 |
Effect of mouse hepatitis virus infection on combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cytosine; Drug Therapy, Combination; Female; Hepat | 1987 |
Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophos | 1987 |
Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
Topics: Animals; Antibodies; Cell Division; Cyclophosphamide; Cytosine; G(M1) Ganglioside; Glycosphingolipid | 1985 |